Rapid Responses to:

NEWS:
David Spurgeon
Continuing education should no longer be funded by drug industry, says CMAJ
BMJ 2008; 336: 742-b-743-b [Full text]
*Rapid Responses: Submit a response to this article

Rapid Responses published:

[Read Rapid Response] Putting our money where our mouths are
Rebecca A. Drayer, Rochester, NY 14625, U.S.A.   (4 April 2008)
[Read Rapid Response] Who will pay
David J Reinhardt   (5 April 2008)
[Read Rapid Response] Re: Who will pay
Alesa Koziol   (12 April 2008)
[Read Rapid Response] Pyment for CME?
sudarshan kumari   (13 April 2008)

Putting our money where our mouths are 4 April 2008
 Next Rapid Response Top
Rebecca A. Drayer,
Instructor of Medicine
University of Rochester School of Medicine,
Rochester, NY 14625, U.S.A.

Send response to journal:
Re: Putting our money where our mouths are

It's all very well and good to decry drug company involvement in medical education (and research), but who else is going to pay for it? The research budget for the United States' National Institutes of Health has been dropping for the last few years. Hospitals and medical schools in the U.S. rely a good deal on Medicare funds to support their broad mission, including teaching, but Medicare payments are also dropping. Anecdotally, there are many stories about good clinical teachers dropping some of their education duties because they must increase direct patient care time.

If we are to eliminate the pharmaceutical industry as a payer for medical education, we need to be very sure there are others able and willing to pick up the responsibility.

Competing interests: None declared

Who will pay 5 April 2008
Previous Rapid Response Next Rapid Response Top
David J Reinhardt,
Neuropsychologist
90808

Send response to journal:
Re: Who will pay

Yes, who will pay for continuing medical education, if not the drug companies? Perhaps we need to look outside our niche to other professions for an answer to this. . Who pays for nursing CEs? Social Workers? Pharmacists? Real Estate agents? Electricians?

Competing interests: None declared

Re: Who will pay 12 April 2008
Previous Rapid Response Next Rapid Response Top
Alesa Koziol,
Clinical Midwifery Educator
St John of God- Berwick, Melbourne, Australia

Send response to journal:
Re: Re: Who will pay

I read David's comment on who pay's for nursing continuing education with interest. The answer is that rhe individual nurse does. Some employers provide access to clinical updates with on site educators,or institutional subscriptions to peer reviewed journals, but in the main in order to remain abreast of current developments within each speciality the nurse pay's....and interestingly many will not attend any education funded by an organisation which is in obvious ethical conflict ie International Board Certified Lactation Consultants would balk at attending education funded by Wyeth

Competing interests: None declared

Pyment for CME? 13 April 2008
Previous Rapid Response  Top
sudarshan kumari,
neonatologist
sunderlal jain hospital, Delhi. India

Send response to journal:
Re: Pyment for CME?

I feel the payment for continuing medical education of medical professionals should be by candidates attending the cme.Presently most share of cme are funded by drug and equipment industries , be the conference at local level or national level.The young medical personnal are most lured by free and may scumb to irrational practices of drug prescription ,obliging the donor.

The conference organisers can cut down the heavy expenditures of five star places and lunches etc and look for alternative places so that payment by candidates is sufficient to meet the expenses and avoid outside financial help. Initially this practice may draw fewer subject for cme, but making programme intersting and need based wil draw more later who are interested in topics and not the ones who attend it for fun or add to biodata only. This practice if implemented by main governing bodies of national socites who monitor local bodies will be a way forward of not accpting free cme from industry. Allpharmaceutical companies spend a lot on advertising, free samples .and funding conferences and cme etc, curtailing this practice may reduce the cost of drugs ,specially in developing countries to the consumer benfit.

The canadian medical association issue should be an example to be followed by other country associations

Competing interests: None declared